Europe PMCopen access
Expanding the horizons of cancer therapy with next-generation 4-1BB agonists: a review of molecular and clinical strategies to maximize efficacy and ensure safety
CD137, 4-1BB, Cancer Immunotherapy, Tnfrsf9, Bispecific Antibody (Bsab), 4-1Bb Agonists
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 4660
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.